Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance

References

• LynnJJChenKFWengYMChiuTFRisk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency departmentHematol Oncol201331418919623303687
   PubMed Web of Science ®Google Scholar
• Del ConteGSessaCvon MoosRPhase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumoursBr J Cancer2014111465165925025963
   PubMed Web of Science ®Google Scholar
• LudwigHVan BelleSBarrett-LeePThe European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patientsEur J Cancer200440152293230615454256
   PubMed Web of Science ®Google Scholar
• HongJWooHSKimHAnemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapyCancer Sci2014105121569157525263825
   PubMed Web of Science ®Google Scholar
• KudererNMDaleDCCrawfordJCoslerLELymanGHMortality, morbidity, and cost associated with febrile neutropenia in adult cancer patientsCancer2006106102258226616575919
   PubMed Web of Science ®Google Scholar
• ShaikhAJBawanySAMasoodNIncidence and impact of baseline electrolyte abnormalities in patients admitted with chemotherapy induced febrile neutropeniaJ Cancer20112626621326626
   PubMed Web of Science ®Google Scholar
• EltingLSRubensteinEBMartinCGIncidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopeniaJ Clin Oncol20011941137114611181679
   PubMed Web of Science ®Google Scholar
• FieldKMDowCMichaelMPart I: Liver function in oncology: biochemistry and beyondLancet Oncol20089111092110119012858
   PubMed Web of Science ®Google Scholar
• GeerseDABindelsAJKuiperMARoosANSpronkPESchultzMJTreatment of hypophosphatemia in the intensive care unit: a reviewCrit Care2010144R14720682049
   PubMed Web of Science ®Google Scholar
• FaresFAzzamNFaresBLarsenSLindkaer-JensenSBenzene-poly-carboxylic acid complex, a novel anti-cancer agent induces apoptosis in human breast cancer cellsPLoS One201492e8515624523856
   PubMed Web of Science ®Google Scholar
• DewiSLarsenSSrimuninnimitVLuYSManuabaTLindkær-JensenBenzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride in the treatment of stage IV breast cancer patientsThe Open Breast Cancer Journal20135715
   Google Scholar
• LarsenSButthongkomvongKManikhasABP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phaseBreast Cancer2014617918925473312
   PubMedGoogle Scholar
• DewiSKristiansenVLindkær-JensenSLarsenSBetween- and within-patient n-level response surface pathway design in dose-finding studiesOpen Access J Clin Trials201466374
   Google Scholar
• CarlsenKHKramerJFagertunHELarsenSLoratadine and terfenadine in perennial allergic rhinitis. Treatment of nonresponders to the one drug with the other drugAllergy19934864314368238798
   PubMed Web of Science ®Google Scholar
• AltmanDGPractical Statistics for Medical ResearchLondonChapman & Hall1990
   Google Scholar
• AndersonTWAn Introduction to Multivariate Statistical Analysis2nd edNew York, NYJohn Wiley & Sons1984
   Google Scholar
• National Cancer Institute [webpage on the Internet]Cancer therapy evaluation program: common toxicity criteria manual611999 Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcmanual_v4_10-4-99.pdfAccessed June 1, 1999
   Google Scholar
• DavidsonMBThakkarSHixJKBhandarkarNDWongASchreiberMJPathophysiology, clinical consequences, and treatment of tumor lysis syndromeAm J Med2004116854655415063817
   PubMed Web of Science ®Google Scholar
• MatsuiKMoriTSawadaMEvaluation of primary prophylaxis with granulocyte colony-stimulating factor for epithelial ovarian cancerEur J Gynaecol Oncol2014351485124654461
   PubMed Web of Science ®Google Scholar
• YuanQHanJCongWDocetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicityInt J Nanomedicine201494829484625378924
   PubMed Web of Science ®Google Scholar
• DeshmukhVKulkarniABhargavaSEffectiveness of combinations of Ayurvedic drugs in alleviating drug toxicity and improving quality of life of cancer patients treated with chemotherapySupport Care Cancer201422113007301524906836
   PubMed Web of Science ®Google Scholar
• VyasPThakarABBaghelMSSisodiaADeoleYEfficacy of Rasayana Avaleha as adjuvant to radiotherapy and chemotherapy in reducing adverse effectsAyu201031441742322048532
   PubMedGoogle Scholar
• GoelHCPrasadJSinghSRadioprotective potential of an herbal extract of Tinospora cordifoliaJ Radiat Res2004451616815133291
   PubMed Web of Science ®Google Scholar
• WangCZCalwayTYuanCSHerbal medicines as adjuvants for cancer therapeuticsAm J Chin Med201240465766922809022
   PubMed Web of Science ®Google Scholar
• ShibataHCancer and electrolytes imbalanceGan To Kagaku Ryoho201037610061010 Japanese20567101
   PubMedGoogle Scholar
• PenackORempfPEisenblätterMBloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood culturesAnn Oncol200718111870187417804478
   PubMed Web of Science ®Google Scholar
• MillerRCSteinbachAGrowth factor use in medication-induced hematologic toxicityJ Pharm Pract201427545346025249588
   PubMedGoogle Scholar
• BicakliDHVarolUDegirmenciMAdjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancerJ Oncol Pharm Pract Epub2014917
   Web of Science ®Google Scholar
• HurvitzSGuerinABrammerMInvestigation of adverse-event-related costs for patients with metastatic breast cancer in a real-world settingOncologist201419990190825085897
   PubMed Web of Science ®Google Scholar
• ChenAChenLAl-QaisiAEverolimus-induced hematologic changes in patients with metastatic breast cancerClin Breast Cancer2015151485325199576
   PubMed Web of Science ®Google Scholar
• HwangSYChangSJParkBWDoes chemotherapy really affect the quality of life of women with breast cancer?J Breast Cancer201316222923523843858
   PubMed Web of Science ®Google Scholar
• KaylAEMeyersCASide-effects of chemotherapy and quality of life in ovarian and breast cancer patientsCurr Opin Obstet Gynecol2006181242816493256
   PubMed Web of Science ®Google Scholar
• LambaJKFridleyBLGhoshTMYuQMehtaGGuptaPGenetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancerPharmacogenomics201415121565157425340731
   PubMed Web of Science ®Google Scholar